Pulmonary Drug Delivery—Particle Engineering for Inhaled Therapeutics
Experts discuss factors affecting drug delivery to the lungs and key considerations when developing inhalation formulations.

Securing the Global API Supply Chain
Recent regulatory initiatives designed to secure the global pharmaceutical supply chain will directly impact the global supply chain and API manufacturers.

Ranbaxy Suspends API Shipments from Two Plants in India
Daiichi Sankyo announced suspension of API shipments from Ranbaxy’s Toansa and Dewas plants; issues apology to stakeholders.

Advertisement: Pharmaceutical Equipment Classifieds & Auctions Visit ProcessX to buy and sell, new and used Capsule Fillers, Inspection Machines, Fluid Bed Dryers and accessories. ProcessX is an online classified and auction website specializing in used process, pharmaceutical, and laboratory equipment, including: coaters, dissolution testing, granulators, tablet presses and more.  Sign up for our “Process Plant Monitor” newsletter and weekly “Process Marketplace” announcements.www.processx.com

Large Industry Cross-Section Contributes to PDA Quality Metrics Recommendations
PDA works with FDA to create pharmaceutical quality metrics.

FDA and EMA Collaborate on Pharmacovigilance
FDA and EMA set up regular meetings to harmonize drug safety actions.

Advertisement: Molded TPE Single-Use Assemblies – Get a Connection Sample Assemblies made from AdvantaFlex® tubing and molded fittings help eliminate barbed fitting risks such as leaks and contamination. AdvantaFlex is free of silicone oils and animal-derived ingredients. Weldable and heat sealable. Validated sterility assurance available. Made in USA. Request a complimentary connection sample or see it at Interphex and the PDA Annual Meeting.www.advantapure.com/sample-pt1

FDA Updates Analytical Validation Guidance
FDA provides recommendations for submitting analytical procedures and methods validation data.

Advertisement: Avoiding Out-of-Specification (OOS) and Aberrant Results: Weighing and Sample Prep Live Webcast: Wednesday March 26, 2014 at 11:00 AM EDT. Register Free at: www.pharmtech.com/avoid_oos

FDA Issues Draft Guidance on NCE Exclusivity Determinations
FDA revises interpretation of the five-year NCE exclusivity provisions for certain fixed-combination drug products.

Actavis to Acquire Forest Laboratories
The combined company will create blockbuster product franchises in the central nervous system, gastroenterology, women's health, urology, and cardiovascular therapeutic categories.

Advertisement: Strategies for Successful Scale-up Using Quality by Design Live Webcast: Thursday March 27 at 2:00 - 3:00 PM EDT To Register free: www.pharmtech.com/scaleup

Almac Adds New Blistering Technology
Almac has added new blistering technology at their US packaging facility in Audubon, PA, as a solution to ease the transition between clinical and commercial launch of blister products.

Fluid Imaging Technologies Seeks Submissions for Research Grant
Fluid Imaging Technologies calls for submissions for its Life Sciences & Materials Research Grant.

Advertisement: Navigating the Analytical Development Challenges for Bioprocess Residuals and Impurities (US Broadcast) Tuesday, April 1, 2014 at 10:00 AM PDT / 12:00 PM CDT / 1:00 PM EDT and (Europe Broadcast) Thursday, April 3, 2014 at 2:00 PM BST / 3:00 PM CEST To Register free: www.pharmtech.com/navigating

Nuevolution Enters License Agreement with Merck
Nuevolution enters a license agreement with a subsidiary of Merck for small molecule compounds.

Join Pharmaceutical Technology in free educational sessions at INTERPHEX 2014 and hear about the latest advances in bio/pharmaceutical manufacturing technology.
Participate in Q&A sessions to get answers to your manufacturing challenges.

Sessions are held on the Innovation Center, Stage 2. Admission to the Innovation Center sessions is free to visitors with an exhibit hall pass. For session details, visit
www.pharmtech.com/interphex2014

Tuesday, March 18
10:30 am–11:15 am: Advances in Hot-Melt Extrusion Manufacturing
11:15 am–noon: Continuous Manufacturing for Solid Dose Drugs
1:30 pm–2:15 pm: High-Potency Manufacturing for Finished Drugs
2:15 pm–3 pm: Implementing Effective Cleaning Validation Programs.

Wednesday, March 19
10:30 am–11:15 am: The Right Business Decisions In Light of the Drug Quality and
11:15 am–noon: Getting More Out of the Contract Services Relationship
1:30 pm–2:15 pm: Continuous Manufacturing for Biologic Drugs
2:15 pm–3 pm: Modular Biopharmaceutical Manufacturing Systems.